Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5151–5200 of 18416
On May 8, 2024, Ken Rizvi notified SMART Global Holdings, Inc. (the “Company”) that after over three years as the Company’s senior vice president and chief financial officer (“CFO”), he intends to resign to pursue another opportunity.
On May 14, 2024, Synaptics Incorporated (the “Company”) announced that Ken Rizvi will join the Company as its Chief Financial Officer, effective on July 15, 2024 (the “Effective Date”).
On the Effective Date, in connection with Mr. Rizvi’s appointment, Michael Hurlston will cease to serve as the Company’s principal financial officer but will continue to serve as the Company’s President and Chief Executive Officer.
J. Stephen Tipton as Chief Executive Officer of Centennial Bank
announced the appointment of L. Dyson Dryden, a director of the Company, as interim Chief Financial Officer for the Company, effective June 1, 2024
The Board of Directors of SEATech Ventures Corp. (the “Company”) received notification from Mr. Prabodh Kumar A/L Kantilal H Sheth that, effective on May 08, 2024, he resigns as Chief Financial Officer of the Company.
James A. Rechtin would become President and Chief Executive Officer at that time.
Bruce D. Broussard, Chief Executive Officer, would be stepping down from that role in the latter half of 2024
On May 7, 2024, Stephen E. Kuczynski, Chairman and Chief Executive Officer of Southern Nuclear Operating Company, Inc. (“Southern Nuclear”) and a named executive officer of The Southern Company, notified Southern Nuclear of his retirement, effective June 28, 2024.
appoint him to serve as the Executive Vice President and Chief Financial Officer ("CFO") of both Horizon and its wholly-owned bank subsidiary, Horizon Bank (the "Bank"), to be effective as of May 20, 2024.
On May 9, 2024, the Board of Directors of the Company (the "Board") notified Scipio "Max" Carnecchia that his employment as the Company's Chief Executive Officer would terminate as of May 31, 2024.
Scott Carter, a member of the Board, has been appointed as Interim Chief Executive Officer, effective as of June 1, 2024.
Michael P. Zechmeister will be departing from his position as Chief Financial Officer of the Company after a successor is appointed or no later than May 31, 2024, at which time Mr. Zechmeister plans to retire.
As previously reported, on March 12, 2024, Stephen L. Faulkner, Jr. (Larry) informed Empire Petroleum Corporation (the "Company") that he was resigning as Chief Financial Officer and Chief Accounting Officer of the Company effective on March 28, 2024.
On May 10, 2024, the Board of Directors of the Company appointed Michael R. Morrisett, the Company’s President and Chief Executive Officer, to temporarily serve as the Company’s principal financial officer until the Company hires a replacement principal financial officer.
On May 13, 2024, the Board of Directors (the “Board”) of V2X, Inc. (the “Company”) announced the appointment of Mr. Jeremy Wensinger as President, Chief Executive Officer (“CEO”), and a Class III Director of the Board, effective June 17, 2024.
Departure of Charles Prow as President, Chief Executive Officer On May 9, 2024, Mr. Prow was separated as President and CEO of the Company, effective June 17, 2024.
On May 8, 2024, the board of directors of Zapata Computing Holdings Inc. (the “Company”) appointed Sumit Kumar as the Company’s Chief Financial Officer, Principal Financial and Accounting Officer and Treasurer effective on May 20, 2024.
On May 8, 2024, Mimi Flanagan, the Chief Financial Officer and Treasurer of the Company, notified the Company that she will be resigning from her positions effective May 20, 2024.
On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the “CFO”) of Oramed Pharmaceuticals Inc. (the “Company”), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.
appointed Scott A. Cox to serve as the sole director of the Board, to hold office until the next annual meeting of stockholders of the Company at which directors are being elected or as set forth in our Amended and Restated Bylaws (as defined below), and as the President, Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary of the Company
In addition, at the Second Merger Effective Time, Scott A. Cox, Chief Executive Officer, ceased serving in such positions.
On May 12, 2024, the Board appointed Ronald T. Nixon, the Company’s Executive Chairman, as the Chief Executive Officer of the Company, effective immediately.
On May 10, 2024 (the “Effective Date”), Zachary B. Fleming delivered notice to the Board of Directors of the Company (the “Board”) that he is resigning from his position as Chief Executive Officer of the Company, effective immediately.
On May 11, 2024, the board of directors (the “Board”) of Marathon Petroleum Corporation (the “Company”) appointed Maryann T. Mannen as Chief Executive Officer of the Company, effective August 1, 2024.
appointed Maryann T. Mannen as President and Chief Executive Officer, effective August 1, 2024.
On May 10, 2024, Equity Bancshares, Inc. (the “Company”) announced the promotion of Richard M. Sems to Chief Executive Officer of Equity Bank.
announced that Joseph Ciaffoni will step down as the President and Chief Executive Officer of Collegium Pharmaceutical, Inc. (the “Company”) effective May 24, 2024.
the Board approved the appointment of Michael Heffernan, the Company’s Chairman of the Board, to Interim President and Chief Executive Officer, effective May 24, 2024
On May 8, 2024, the Board of the Company appointed Rajneesh Vig to the Board of Directors the Company as Chair and appointed him as Chief Executive Officer (“CEO”) of the Company, with the appointments effective immediately.
On April 1, 2024, the Company issued a press release announcing Claudia Jaramillo’s departure from the Company and Kevin Berryman’s appointment as the Company’s interim Chief Financial Officer.
On April 1, 2024, the Company issued a press release announcing Claudia Jaramillo’s departure from the Company and Kevin Berryman’s appointment as the Company’s interim Chief Financial Officer.
On May 10, 2024, Mr. Anthony Geisler, Chief Executive Officer and Director of Xponential Fitness, Inc. (the “Company”), was removed by the Company’s Board of Directors from his duties and suspended indefinitely as Chief Executive Officer.
The Company’s Board of Directors has appointed Ms. Brenda Morris, a member of the Company’s Board of Directors since 2019, to serve as the Company’s Interim Chief Executive Officer.
Ms. Shirley Cheng, the Chief Financial Officer, Corporate Secretary and Director of Network CN Inc. (the “Company”) notified the Company of her intention to resign from her position for personal reasons. Ms. Cheng’s resignation will become effective on May 12, 2024.
the Board appointed Adam K. Peterson as the sole Chairman and sole Chief Executive Officer of the Company, succeeding Mr. Rozek
On May 6, 2024, A. Allen Arroyo, Chief Financial Officer, principal financial officer and principal accounting officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”), notified the Company of his intention to resign effective May 17, 2024.
the Board appointed Mr. Liu as President/CEO
Mr. Wang as CFO
On May 10, 2024, Brixmor Property Group Inc. (the “Company”) announced that James M. Taylor Jr., the Company’s Chief Executive Officer and President, will return from his medical leave of absence and reassume his duties as the Company’s Chief Executive Officer and President, effective May 20, 2024.
On the Effective Date, the Company appointed Mark Boelke as Chief Financial Officer and Treasurer of the Company, effective immediately.
On May 9, 2024 (the "Effective Date"), Entravision Communications Corporation (the “Company”) terminated the employment of Christopher T. Young, Chief Financial Officer, and Juan Saldívar von Wuthenau, Chief Strategy and Business Development Officer, each effective immediately.
On May 9, 2024, Quaker Chemical Corporation (the “Company”) announced the termination of the employment of Shane Hostetter, as the Company’s Chief Financial Officer, effective as of June 7, 2024.
On May 6, 2024, the Board of Directors of the Company appointed Tom Coler, age 50, to Executive Vice President and Chief Financial Officer, effective June 10, 2024.
Effective May 9, 2024, Mina Kim was appointed as the Chief Executive Officer of the Company and was appointed as a member of the Board of Directors of the Company (the “Board”).
By mutual agreement of Shao-Lee Lin, M.D., Ph.D. and the Company, Dr. Lin stepped down from her position as Chief Executive Officer and as a member of the Board, effective on May 8, 2024.
On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date
On May 3, 2024, Wesley Sima resigned as Chief Financial Officer of RMG Acquisition Corp. III (the “Company”).
On May 3, 2024, Brian Zasitko, Chief Financial Officer of the Company, resigned, effective May 17, 2024.
the Board appointed Ryan Confer, Chief Financial Officer of Genprex since 2016, to serve as President and Chief Executive Officer of Genprex (in addition to his position as Chief Financial Officer of Genprex), effective immediately
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.